COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Automated Tele Counseling for Screening Mammography

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00247013
Recruitment Status : Completed
First Posted : November 1, 2005
Last Update Posted : February 22, 2016
Massachusetts General Hospital
Information provided by:
Boston Medical Center

Brief Summary:
The purpose and aim of this study is to test the use of a computer-based, automated telecommunications system and its effectiveness in increasing the rates of regular screening mammography among women ages 50-74. The system will not only help in scheduling appointments but will help women in overcoming any barriers that may deter them from having the procedure at all. The programs are designed to be user friendly and easy to implement in clinical practice.

Condition or disease Intervention/treatment Phase
Breast Cancer Behavioral: Breast Cancer Screening Compliance Phase 1

Detailed Description:
The primary goal of this project is to evaluate the effectiveness and acceptability of a computer-based telecommunications system for increasing rates of regular screening mammography among women ages 50-74. The Telephone-Linked-Communications for Mammography Screening (TLC-M) is designed to educate, advise and motivate women to have regular screening mammograms. There will be two versions of TLC-M: one for women who are coming due for their annual screening mammography ("pre-due" women) and one for women who have missed their annual mammogram ("past-due" women). TLC-M uses a real human voice to speak to the women on the telephone; the subjects communicate by using the touch tone keypad on their telephones. The intervention will consist of up to three automated telephone conversations. During the call TLC-M assesses the woman's willingness to have a mammogram, helps interested women schedule a mammogram, and identifies and addresses difficulties or barriers she might have in getting a mammogram. This study will consist of two linked randomized controlled trials. We will recruit 2,120 participants over 12 months from two radiology departments. Three to four months prior to their due date for an annual screening mammogram, these women will receive a reminder letter to schedule a mammogram. In addition, a random sample of them will use TLC-M. All participants in this "pre-due" intervention study will be evaluated 3 months after their due date to determine whether or not they obtained a mammogram. Of the women who received the letter only in the first trial, those who did not obtain a mammogram during the observation period will enter a "past due" intervention trial. These women will be randomly assigned to receive a "past due" reminder letter or to use the TLC-M. Four months later, participants will be evaluated to determine whether they had a mammogram. For both trials mammography rates of those women who used the TLC-M and those who did not will be statistically compared.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 2120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Official Title: Automated Tele Counseling for Screening Mammography
Study Start Date : January 1996
Study Completion Date : January 2006

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Number of women who have repeat screening mammogram

Secondary Outcome Measures :
  1. Evaluation of intervention for those women who used TLC-M

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   50 Years to 74 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Ages 50-74
  • A recent (within the last 6 months) negative screening mammogram

Exclusion Criteria:

  • Lack a permanent address or planning to move from the Boston area during the study period
  • No home telephone or no touch tone service
  • Cannot use a telephone unassisted
  • Cannot understand conversational English over the telephone
  • Major medical illness that would preclude participation
  • History of breast cancer
  • Mammography or other breast diagnostic procedures (except CBE) or therapeutic procedures since the last screening mammogram
  • Another member of household enrolled in the study (to eliminate possible study contamination)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00247013

Layout table for location information
United States, Massachusetts
Boston Medical Center
Boston, Massachusetts, United States, 02118
Sponsors and Collaborators
Boston Medical Center
Massachusetts General Hospital
Layout table for investigator information
Principal Investigator: Robert Friedman, MD Boston University
Layout table for additonal information Identifier: NCT00247013    
Other Study ID Numbers: R01CA084447-01 ( U.S. NIH Grant/Contract )
National Cancer Institute
First Posted: November 1, 2005    Key Record Dates
Last Update Posted: February 22, 2016
Last Verified: September 2010
Keywords provided by Boston Medical Center:
automated telephone system
breast cancer
cancer prevention
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases